Nevertheless, because we are not dissecting the pathogenic role of Th17 cells in psoriasis but rather using them as a robust model system to measure CYP1A1 enzymatic activity, their usage is not in contrast with the beneficial role of the AHR pathway. The gene discussed is CYP1A1; the disease is psoriasis.